UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL

Molecular human reproduction, 2014-02, Vol.20 (2), p.168-177

2014

Volltextzugriff (PDF)

A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients

Annals of oncology, 2013-10, Vol.24 (10), p.2686-2693

2013

Volltextzugriff (PDF)

Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells

Gene therapy, 2014-03, Vol.21 (3), p.262-271

2014

Volltextzugriff (PDF)

Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy

Gene therapy, 2013-11, Vol.20 (11), p.1085-1092

2013

Volltextzugriff (PDF)

Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells

Gene therapy, 2012-12, Vol.19 (12), p.1133-1140

2012

Volltextzugriff (PDF)

Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors

Gene therapy, 2006-04, Vol.13 (7), p.630-640

2006

Volltextzugriff (PDF)

3328 A randomized controlled phase II clinical trial on autologous monocyte-derived mRNA electroporated dendritic cells for stage III/IV melanoma patients who are disease-free following the local treatment of macrometastases

European journal of cancer (1990), 2015-09, Vol.51, p.S673-S673

2015

Volltextzugriff (PDF)

Phosphorylated STAT3 physically interacts with NPM and transcriptionally enhances its expression in cancer

Oncogene, 2015-03, Vol.34 (13), p.1650-1657

2015

Volltextzugriff (PDF)

In vitro generation of mature, naive antigen-specific CD8(+) T cells with a single T-cell receptor by agonist selection

Leukemia, 2014-04, Vol.28 (4), p.830-841

2014

Volltextzugriff (PDF)

Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines

Gene therapy, 2005-05, Vol.12 (9), p.772-782

2005

Volltextzugriff (PDF)

1090 Tumor-associated Antigen Validation in Uterine Tumors

European journal of cancer (1990), 2012-07, Vol.48, p.S262-S262

2012

Volltextzugriff (PDF)

RASSF4 functions as a tumor suppressor in Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e227-e227

2015

Volltextzugriff (PDF)

Development of an ex vivo assay measuring T cells with indirect alloreactivity using messenger RNA electroporation

Transplant immunology, 2014-10, Vol.31 (4), p.248-248

2014

Volltextzugriff (PDF)

P4 Preclinical evaluation of an mRNA-based therapeutic HIV vaccine candidate combining rationally selected antigenic sequences and potent adjuvant signals (HTI-TriMix)

Journal of Virus Eradication, 2016-09, Vol.2, p.5-5

2016

Volltextzugriff (PDF)

Induction of antigen-specific CD8 cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA

Gene therapy, 2006-07, Vol.13 (13), p.1027-1036

2006

Volltextzugriff (PDF)

Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma

Journal of immunotherapy (1997), 2011-06, Vol.34 (5), p.448

2011

Volltextzugriff (PDF)

P18-03. Dendritic cell-based immune therapy against HIV-1

Retrovirology, 2009-10, Vol.6 (S3), p.P312-P312, Article P312

2009

Volltextzugriff (PDF)

Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules

The Journal of immunology (1950), 2004-06, Vol.172 (11), p.6649-6657

2004

Volltextzugriff (PDF)

Loading of dendritic cells for immunotherapy

ISBT science series, 2013-06, Vol.8 (1), p.161-164

2013

Volltextzugriff (PDF)

Dendritic Cells Genetically Engineered to Express IL-10 Induce Long-Lasting Antigen-Specific Tolerance in Experimental Asthma

The Journal of immunology (1950), 2008-11, Vol.181 (10), p.7230-7242

2008

Volltextzugriff (PDF)

CD8α+ and CD8α− Subclasses of Dendritic Cells Direct the Development of Distinct T Helper Cells In Vivo

The Journal of experimental medicine, 1999-02, Vol.189 (3), p.587-592

1999

Volltextzugriff (PDF)

Lentivirally transduced dendritic cells as a tool for cancer immunotherapy

The journal of gene medicine, 2003-08, Vol.5 (8), p.654-667

2003

Volltextzugriff (PDF)

Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors

Human gene therapy, 2007-06, Vol.18 (6), p.536

2007

Volltextzugriff (PDF)

Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy

The journal of gene medicine, 2005-06, Vol.7 (6), p.686-695

2005

Volltextzugriff (PDF)

Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells

The journal of gene medicine, 2004-11, Vol.6 (11), p.1175-1188

2004

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(112)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(60)
Humans
(43)
Animals
(26)
Dendritic Cells - Immunology
(26)
Immunology
(25)
Biological And Medical Sciences
(22)
Dendritic Cells
(19)
Female
(19)
Medicine, Research & Experimental
(19)
Mice
(19)
Research & Experimental Medicine
(19)
Immunotherapy
(18)
Medical Sciences
(18)
Genetics & Heredity
(17)
Biotechnology & Applied Microbiology
(16)
Oncology
(14)
Male
(13)
Antigen Presentation
(12)
Electroporation
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL

A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients

Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells

Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy

Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells

Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors

3328 A randomized controlled phase II clinical trial on autologous monocyte-derived mRNA electroporated dendritic cells for stage III/IV melanoma patients who are disease-free following the local treatment of macrometastases

Phosphorylated STAT3 physically interacts with NPM and transcriptionally enhances its expression in cancer

In vitro generation of mature, naive antigen-specific CD8(+) T cells with a single T-cell receptor by agonist selection

Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines

1090 Tumor-associated Antigen Validation in Uterine Tumors

RASSF4 functions as a tumor suppressor in Multiple Myeloma

Development of an ex vivo assay measuring T cells with indirect alloreactivity using messenger RNA electroporation

P4 Preclinical evaluation of an mRNA-based therapeutic HIV vaccine candidate combining rationally selected antigenic sequences and potent adjuvant signals (HTI-TriMix)

Induction of antigen-specific CD8 cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA

Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma

P18-03. Dendritic cell-based immune therapy against HIV-1

Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules

Loading of dendritic cells for immunotherapy

Dendritic Cells Genetically Engineered to Express IL-10 Induce Long-Lasting Antigen-Specific Tolerance in Experimental Asthma

CD8α+ and CD8α− Subclasses of Dendritic Cells Direct the Development of Distinct T Helper Cells In Vivo

Lentivirally transduced dendritic cells as a tool for cancer immunotherapy

Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors

Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy

Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells

Suchergebnisse filtern